A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis, a high concentration of red blood cells, with the use of prescribed testosterone.
Hormone therapy for transmasculine individuals may be safer than previously thought
- Post author:
- Post published:November 27, 2023
- Post category:uncategorized